The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation
By Jonathan Noonan, Research Officer, Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute
Karlheinz Peter, Lab Head, Atherothrombosis and Vascular Biology and Deputy Director, Baker Heart and Diabetes Institute; Interventional Cardiologist, Alfred Hospital; Professor of Medicine and Immunology, Monash University, Baker Heart and Diabetes Institute
A small number of cases of myocarditis and pericarditis have been reported following the mRNA COVID vaccines developed by Pfizer and Moderna. But this is no reason to avoid the jab.
Read complete article
© The Conversation
- Wednesday, July 21, 2021